Trial Profile
A Phase 2, Open-Label Extension Study of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2020
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Cellulite
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 12 Jul 2018 Status changed from active, no longer recruiting to completed.
- 16 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 15 Jun 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.